| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 01/31/2013 | WO2013014295A1 Process for preparing prasugrel |
| 01/31/2013 | WO2013013765A1 Small molecules and their use as organic semiconductors |
| 01/31/2013 | US20130030183 Process for preparing a pharmaceutical compound |
| 01/31/2013 | US20130029984 Heterocyclic compounds and uses thereof |
| 01/31/2013 | US20130029983 Aminothienopyridazine inhibitors of tau assembly |
| 01/31/2013 | US20130029982 Heterocyclic compounds and uses thereof |
| 01/31/2013 | US20130029970 CB Receptor Agonists |
| 01/31/2013 | US20130029969 Heterocyclic compound |
| 01/31/2013 | US20130029942 Compounds and therapeutical uses thereof |
| 01/30/2013 | EP2550278A1 Analogues for the treatment or prevention of flavivirus infections |
| 01/30/2013 | EP2550268A1 Analogues for the treatment or prevention of flavivirus infections |
| 01/30/2013 | EP2550267A1 Analogues for the treatment or prevention of flavivirus infections |
| 01/30/2013 | EP2550262A1 Analogues for the treatment or prevention of flavivirus infections |
| 01/30/2013 | EP2549868A1 Chemical compounds |
| 01/30/2013 | CN102898437A Acid-addition salt of Prasugrel, preparation method and application |
| 01/30/2013 | CN102134248B Multi-sulfo-disulfide alkene nickel coordination compound and preparation method and application thereof |
| 01/30/2013 | CN101962387B Clopidogrel bisulfate in novel crystalline form and preparation method thereof |
| 01/30/2013 | CN101948479B 普拉格雷中间体及其制备方法 Prasugrel intermediates and preparation method |
| 01/29/2013 | US8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 01/29/2013 | US8362068 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors |
| 01/29/2013 | US8362003 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 01/29/2013 | US8361500 Tablet formulations containing 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom |
| 01/24/2013 | WO2013012909A1 Kinase inhibitor with improved aqueous solubility |
| 01/24/2013 | WO2013012297A1 Novel organic electroluminescence compounds and organic electroluminescence device using the same |
| 01/24/2013 | WO2013012296A1 Novel organic electroluminescence compounds and organic electroluminescence device using the same |
| 01/24/2013 | WO2013011891A1 Nitrogenated aromatic heterocyclic derivative, and organic electroluminescent element using same |
| 01/24/2013 | WO2013010615A1 Conjugated polymers |
| 01/24/2013 | WO2013010614A2 Organic semiconductors |
| 01/24/2013 | WO2013010502A1 Acid addition salt of prasugrel, preparation method therefor and use thereof |
| 01/24/2013 | WO2012129511A3 Semiconducting compounds and devices incorporating same |
| 01/24/2013 | US20130023673 Preparation Method of 3,4-Ethylenedioxythiophene |
| 01/24/2013 | US20130023555 Kinase inhibitor with improved solubility profile |
| 01/24/2013 | US20130020563 Polycyclic compounds and organic electroluminescence device employing the same |
| 01/23/2013 | EP2548875A1 Preparation method of 3,4-ethylenedioxythiophene |
| 01/23/2013 | CN102892769A Process for preparing dithiine-tetracarboxy-diimides |
| 01/23/2013 | CN102887891A N4-phenyl-quinaz0line-4 -amine derivatives and related compounds |
| 01/23/2013 | CN101940214B Spiropiperidine derivatives for controlling pests |
| 01/23/2013 | CN101855227B Heterocyclic derivatives |
| 01/22/2013 | CA2494920C Photochromic and electrochromic compounds and methods of synthesizing and using same |
| 01/17/2013 | WO2013008981A1 Spherical particles of clopidogrel bisulfate, pharmaceutical composition including same, and method for manufacturing same |
| 01/17/2013 | WO2013008872A1 Novel compound having parp inhibitory activity |
| 01/17/2013 | WO2013008217A1 4 - piperidinyl compounds for use as tankyrase inhibitors |
| 01/17/2013 | WO2013007334A2 Conjugated polymers |
| 01/17/2013 | WO2012068234A3 Antiviral compounds |
| 01/17/2013 | US20130018057 Quinoline and Quinoxaline Derivatives as Kinase Inhibitors |
| 01/17/2013 | US20130018052 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors |
| 01/17/2013 | US20130018038 Chemical compounds |
| 01/17/2013 | CA2841932A1 4 - piperidinyl compounds for use as tankyrase inhibitors |
| 01/17/2013 | CA2841897A1 Novel compound having parp inhibitory activity |
| 01/16/2013 | EP2545059A1 A process for making prasugrel |
| 01/16/2013 | CN102884068A Thienopyridine derivative, method for producing same and organic semiconductor device using same |
| 01/16/2013 | CN102884061A Method of making coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling |
| 01/16/2013 | CN102875568A Method for preparing (+)-(S)-clopidogrel hydrogen sulfate pure crystal type I |
| 01/16/2013 | CN102875567A Piperazine compound and preparation and usage thereof |
| 01/16/2013 | CN102875566A Thiophene derivatives with anti-gastric ulcer effect |
| 01/16/2013 | CN102872018A Tyrosine kinase irreversible inhibitor and preparation method and applications thereof |
| 01/16/2013 | CN101717630B Hole transmission material for enhancing hole transmission capacity and preparation method thereof |
| 01/15/2013 | US8354423 Insecticidal spironindane derivatives |
| 01/15/2013 | US8354415 Thienopyrimidine compounds and compositions |
| 01/10/2013 | WO2013006738A1 Compounds for the treatment of hiv |
| 01/10/2013 | WO2013005798A1 Novel nitrogenated heterocyclic ring derivative |
| 01/10/2013 | US20130012703 2,4,7-substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitors |
| 01/10/2013 | US20130012700 Materials for organic electroluminescent devices |
| 01/10/2013 | US20130012488 Benzoxepin pi3k inhibitor compounds and methods of use |
| 01/10/2013 | US20130011362 Targeting monomers and polymers having targeting blocks |
| 01/10/2013 | CA2840095A1 Compounds for the treatment of hiv |
| 01/09/2013 | EP2543667A1 2-aminopyridine analogs as glucokinase activators |
| 01/09/2013 | EP2542545A1 Inhibitors of hepatitis c virus ns5b polymerase |
| 01/09/2013 | CN102869669A Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 01/09/2013 | CN102869668A Process for making prasugrel |
| 01/09/2013 | CN102869662A Organic electroluminescence devices |
| 01/09/2013 | CN102869659A Bicarbazole containing compounds for OLEDs |
| 01/09/2013 | CN102869657A Analogues for the treatment or prevention of flavivirus infections |
| 01/09/2013 | CN102863812A Organic dye and dye-sensitized solar cell |
| 01/09/2013 | CN102863457A Optically-active 2- hydroxyltetrathienopyridine derivative, preparation method thereof and application of optically-active 2- hydroxyltetrathienopyridine derivative to pharmacy |
| 01/09/2013 | CN102863310A Rigid oligomer-fullerene copolymer and preparation method and application thereof |
| 01/09/2013 | CN102120744B Optical-activity 2-hydroxytetrahydrothienopyridine derivative, preparation method and application thereof in pharmacy |
| 01/09/2013 | CN101402642B Novel environment friendly preparation method for prasugrel |
| 01/08/2013 | US8350256 Organic semiconductor compounds |
| 01/08/2013 | CA2556081C 2-halofuryl/thienyl-3-carboxamides |
| 01/08/2013 | CA2507710C Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators |
| 01/03/2013 | WO2013003383A1 Bridged bicyclic compounds for the treatment of bacterial infections |
| 01/03/2013 | WO2013001544A1 Anti-thrombotic compounds |
| 01/03/2013 | WO2013001498A1 Amidoalkylpiperazinyl derivatives for the treatment of central nervous system diseases |
| 01/03/2013 | US20130005991 Intermediates of 1-o-acyl-2-deoxy-2-fluoro-4-thio-beta-d-arabinofuranoses |
| 01/03/2013 | US20130005989 Heterocyclic quinoid thiophene organic photoelectric material, preparation method and application thereof |
| 01/03/2013 | US20130005979 Thienopyridine derivative, method for producing same and organic semiconductor device using same |
| 01/03/2013 | US20130005762 Combination of droloxifene and clopidogrel |
| 01/03/2013 | US20130005705 Novel inhibitor compounds of phosphodiesterase type 10a |
| 01/03/2013 | US20130005701 Substituted oxazolidinones and their use in the field of blood coagulation |
| 01/03/2013 | CA2840060A1 Bridged bicyclic compounds for the treatment of bacterial infections |
| 01/03/2013 | CA2839608A1 Anti-thrombotic compounds |
| 01/02/2013 | EP2540728A1 Heterocyclic compound |
| 01/02/2013 | EP2539346A1 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 01/02/2013 | EP2539345A1 4 - [cycloalkyloxy (hetero) arylamino]thieno [2, 3 - d]pyrimidines having mnkl/ mnk2 inhibiting activity for pharmaceutical compositions |
| 01/02/2013 | EP2539344A1 Halogen or cyano substituted thieno [2,3-d]pyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions |
| 01/02/2013 | EP2539343A1 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions |
| 01/02/2013 | CN102858783A Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions |
| 01/02/2013 | CN102858782A 4 - [cycloalkyloxy (hetero) arylamino] thieno [2, 3 - d] pyrimidines having mnkl/ mnk2 inhibiting activity for pharmaceutical compositions |
| 01/02/2013 | CN102858772A Imidazo[1,2-a]pyridine derivative |